|
drug interaction paxil Se events meeting these criteria were: Abnormal ejaculation drug interaction paxil, somnolence drug interaction paxil, impotence drug interaction paxil, libido decreased drug interaction paxil, tremor drug interaction paxil, sweating drug interaction paxil, and female genital disorders (generally anorgasmia or difficulty achieving orgasm). Social Anxiety Disorder: In the social anxiety disorder study drug interaction paxil, the adverse events meeting these criteria were: Nausea drug interaction paxil, asthenia drug interaction paxil, abnormal ejaculation drug interaction paxil, sweating drug interaction paxil, somnolence drug interaction paxil, impotence drug interaction paxil, insomnia drug interaction paxil, and libido decreased. Premenstrual Dysphoric Disorder: The most commonly observed adverse events associated with the use of PAXIL CR either during continuous dosing or luteal phase dosing (incidence of 5% or greater and incidence for PAXIL CR at least twice that for p drug interaction paxil.
drug interaction paxil Lacebo drug interaction paxil, derived from Table 5) were: Nausea drug interaction paxil, asthenia drug interaction paxil, libido decreased drug interaction paxil, somnolence drug interaction paxil, insomnia drug interaction paxil, female genital disorders drug interaction paxil, sweating drug interaction paxil, dizziness drug interaction paxil, diarrhea drug interaction paxil, and constipation. In the luteal phase dosing PMDD trial drug interaction paxil, which employed dosing of 12.5 mg day or 25 mg day of PAXIL CR limited to the 2 weeks prior to the onset of menses over 3 consecutive menstrual cycles drug interaction paxil, adverse events were evaluated during the first 14 days of each off-drug phase. When the 3 off-drug phases were combined drug interaction paxil, the following adverse events were reported at an incidence of 2% or greater for PAXIL CR and were at least twice the rate of that reported for placebo: Infection (5.3% versus 2.5%) drug interaction paxil, depression (2.8% versus 0.8%) drug interaction paxil, insomnia (2.4% versus 0.8%) drug interaction paxil, sinusitis (2.4% versus 0%) drug interaction paxil, and asthenia (2.0% versus 0.8%). Incidence in Controlled Clinical Trials: Table 1 enumerates adverse events that occurred at an incidence of 1% or more among patients treated with PAXIL CR drug interaction paxil, aged 18 to 65 drug interaction paxil, who participated in 2 short-term (12-week) placebo-controlled trials in major depressive disorder in which patients were dosed in a range of 25 mg to 62.5 mg day. Table 2 enumerates adverse events reported at an incidence of 5% or greater among elderly patients (ages 60 to 88) treated with PAXIL CR who participated in a short-term (12-week) placebo-controlled trial in major d.
drug interaction paxil Ssion (2.8% versus 0.8%) drug interaction paxil, insomnia (2.4% versus 0.8%) drug interaction paxil, sinusitis (2.4% versus 0%) drug interaction paxil, and asthenia (2.0% versus 0.8%). Incidence in Controlled Clinical Trials: Table 1 enumerates adverse events that occurred at an incidence of 1% or more among patients treated with PAXIL CR drug interaction paxil, aged 18 to 65 drug interaction paxil, who participated in 2 short-term (12-week) placebo-controlled trials in major depressive disorder in which patients were dosed in a range of 25 mg to 62.5 mg day. Table 2 enumerates adverse events reported at an incidence of 5% or greater among elderly patients (ages 60 to 88) treated with PAXIL CR who participated in a short-term (12-week) placebo-controlled trial in major de.
drug interaction paxil 
drug interaction paxil | | | | | |
drug interaction paxil
|
